Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/4299582

Documents

Beta release

Statistics of Fixed-duration epcoritamab plus R 2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Statistics for this year
PeriodVisitsDownloads
202600
Statistics for the last 3 months
PeriodVisitsDownloads
2026-0200
2026-0300
2026-0400